Biogen Inc. buy Truist Financial Co.
Start price
25.03.24
/
50%
€199.50
Target price
25.03.25
€313.72
Performance (%)
-5.54%
Price
02.08.24
€188.45
Summary
This prediction is currently active. With a performance of -5.54%, the BUY prediction by Truist_Financial_Co_ is trending in the wrong direction. This prediction currently runs until 25.03.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -3.086% | -3.086% |
iShares Core DAX® | -3.935% | -2.628% |
iShares Nasdaq 100 | -3.608% | -9.283% |
iShares Nikkei 225® | -4.513% | -6.951% |
iShares S&P 500 | -2.607% | -4.402% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $340.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat